Stuart Chaffee

Stuart Chaffee joined in March 2021 and brings over 20 years of R&D, business and corporate development experience to Affinivax. Most recently, Dr. Chaffee served as the Chief Business Officer and Chief Financial Officer of Praxis Precision Medicines. Dr. Chaffee’s business-building background in drug discovery and development includes his role as Entrepreneur in Residence at Atlas Venture where he was co-founder and Head of Business Operations at Kymera Therapeutics. Earlier in his career, Dr. Chaffee served in a number of roles at Biogen across Finance, Business Development, Program Leadership, and Corporate Strategy. Dr. Chaffee received a B.S. in chemistry from The College of William and Mary, a PhD in organic chemistry from Yale University, and an MBA in finance from the Wharton School of the University of Pennsylvania.